These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28278299)

  • 21. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M; Theede K; Nielsen AM
    Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Fong SC; Blaker PA; Arenas-Hernandez M; Marinaki AM; Sanderson JD
    Biomark Med; 2015; 9(1):51-65. PubMed ID: 25605455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of allopurinol on the pharmacokinetics of 6-mercaptopurine in rabbits.
    Tterlikkis L; Day JL; Brown DA; Schroeder EC
    Cancer Res; 1983 Apr; 43(4):1675-9. PubMed ID: 6682007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of allopurinol to manage skewed 6-mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatment.
    Lines M; Kemper RM; Wallace J; Alexander T; Echols C; Garner LM; Kaplan JB; Thompson P; Crona DJ; Phillips K
    Eur J Haematol; 2024 Nov; 113(5):584-592. PubMed ID: 38989562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro metabolism of 6-mercaptopurine by human liver cytosol.
    Rowland K; Lennard L; Lilleyman JS
    Xenobiotica; 1999 Jun; 29(6):615-28. PubMed ID: 10426560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
    Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Meijer B; Seinen ML; van Egmond R; Bouma G; Mulder CJJ; van Bodegraven AA; de Boer NKH
    Inflamm Bowel Dis; 2017 Nov; 23(11):2011-2017. PubMed ID: 28617756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review.
    Deswal S; Srivastava A
    J Clin Exp Hepatol; 2017 Mar; 7(1):55-62. PubMed ID: 28348471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.
    Haglund S; Taipalensuu J; Peterson C; Almer S
    Br J Clin Pharmacol; 2008 Jan; 65(1):69-77. PubMed ID: 17662091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
    Kiszka-Kanowitz M; Theede K; Nielsen AM
    Ugeskr Laeger; 2015 Jun; 177(26):1253-5. PubMed ID: 26550625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.
    Min MX; Weinberg DI; McCabe RP
    J Clin Pharm Ther; 2014 Apr; 39(2):107-11. PubMed ID: 24438369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
    Gilissen LP; Bierau J; Derijks LJ; Bos LP; Hooymans PM; van Gennip A; Stockbrügger RW; Engels LG
    Aliment Pharmacol Ther; 2005 Oct; 22(7):605-11. PubMed ID: 16181300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites.
    Elgemeie GH
    Curr Pharm Des; 2003; 9(31):2627-42. PubMed ID: 14529546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
    Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
    Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport and metabolism of 6-thioguanine and 6-mercaptopurine in mouse small intestine.
    Bronk JR; Lister N; Shaw MI
    Clin Sci (Lond); 1988 Jun; 74(6):629-38. PubMed ID: 3396300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of thiopurine metabolite monitoring in inflammatory bowel disease.
    Beswick L; Friedman AB; Sparrow MP
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):383-92. PubMed ID: 24684593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia.
    Bostrom B; Erdmann G
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):80-6. PubMed ID: 8447563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Holmstrøm RB; Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C
    Dig Dis Sci; 2018 Jun; 63(6):1583-1591. PubMed ID: 29564674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease.
    Morales A; Salguti S; Miao CL; Lewis JD
    Inflamm Bowel Dis; 2007 Apr; 13(4):380-5. PubMed ID: 17206711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.